IP Library Granted Patent US 10,827,956
Granted Patent B2
US 10,827,956 · App. 16/790,435 · Granted Nov 10, 2020

Analyte sensor

Inventors: Mark C. Brister (Encinitas, CA); Peter C. Simpson (San Diego, CA); Matthew D. Wightlin (San Diego, CA); Steve Masterson (Encinitas, CA); James R. Petisce (San Diego, CA); John Nolting (Poway, CA); Jack Pryor (San Diego, CA); Sean Saint (San Diego, CA); Vance Swanson (San Diego, CA); James H. Brauker (Coldwater, MI); Apurv Ullas Kamath (San Diego, CA); Paul V. Goode, Jr. (Round Rock, TX); Aarthi Mahalingam (San Diego, CA)
Assignee: DexCom, Inc.
A61B5/14532A61B5/0002A61B5/0004A61B5/05A61B5/1411A61B5/1473A61B5/1486A61B5/1495A61B5/14503A61B5/14507A61B5/14514A61B5/14546A61B5/14735A61B5/14865A61B5/6801A61B5/6833A61B5/6848A61B5/6849A61B5/68335A61B5/72A61B17/3468A61B5/14A61B5/145A61B5/1468A61B5/150022A61B2017/3492A61B2560/0223A61B2560/045A61B2562/18A61M5/14244A61M5/1723A61M2005/1585Y02A90/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,827,956
App. No.
16/790,435
Granted
Nov 10, 2020
Kind
B2
Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims (27)

1. An analyte monitoring system comprising:

a first component comprising:

a transcutaneous analyte sensor having an in vivo portion and an ex vivo portion, wherein the transcutaneous analyte sensor is configured to measure a signal indicative of analyte concentration in a host;

electrical contacts operably connected to the transcutaneous analyte sensor,

wherein the first component is associated with a sensor code, wherein the sensor code is associated with calibration information, and wherein the calibration information enables calibration of sensor data without requiring a reference analyte measurement during sensor use; and

a second component separate from the first component, wherein the second component comprises:

sensor electronics configured to be operably connected to the transcutaneous analyte sensor through the electrical contacts of the first component when the second component is attached to the first component by the host, wherein the sensor electronics are configured to wirelessly communicate with a receiver, and wherein the second component is associated with the sensor code.

2. The analyte monitoring system of claim 1 , wherein the first component and the second components are both labeled with the sensor code.

3. The analyte monitoring system of claim 2 , wherein at least one of the first component and the second component comprise a package, and wherein the package is labeled with the sensor code.

4. The analyte monitoring system of claim 3 , wherein the sensor code is alphanumeric.

5. The analyte monitoring system of claim 1 , wherein the sensor code is alphanumeric.

6. The analyte monitoring system of claim 1 , wherein the second component is configured to transmit information associated with the sensor code to the receiver.

7. The analyte monitoring system of claim 1 , wherein the electrical contacts are operably connected to the ex vivo portion of the transcutaneous sensor.

8. The analyte monitoring system of claim 1 , wherein the first component comprises a contact holder.

9. The analyte monitoring system of claim 8 , wherein the first component comprises a seal located over at least a portion of the contact holder.

10. The analyte monitoring system of claim 9 , wherein the seal at least partially surrounds the ex vivo portion of the transcutaneous sensor.

11. The analyte monitoring system of claim 9 , wherein the seal at least partially surrounds the electrical contacts.

12. The analyte monitoring system of claim 1 , wherein the transcutaneous analyte sensor is radiation sterilized.

13. The analyte monitoring system of claim 12 , wherein the sensor electronics are not radiation sterilized.

14. The analyte monitoring system of claim 1 , further comprising an applicator.

15. The analyte monitoring system of claim 14 , wherein one or both of the first component and the second component is coupled to the applicator.

16. The analyte monitoring system of claim 14 , wherein the first component comprises a mounting unit operably connectable to the transcutaneous analyte sensor.

17. The analyte monitoring system of claim 1 , wherein the first component comprises a mounting unit operably connectable to the transcutaneous analyte sensor.

18. The analyte monitoring system of claim 17 , wherein the mounting unit is operably connected to the applicator.

19. The analyte monitoring system of claim 14 , wherein the applicator and the first component are configured to be operably connected by the host prior to the start of the sensor use.

20. The analyte monitoring system of claim 1 , wherein the calibration information associated with the sensor code is stored in the sensor electronics.

21. The analyte monitoring system of claim 1 , wherein the sensor electronics are attachable to multiple different sensors.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2020
From: BRAUKER, JAMES H.; KAMATH, APURV ULLAS; GOODE, PAUL V., JR.; MAHALINGAM, AARTHI
To: DEXCOM, INC.
Reel/Frame 053739/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: MASTERSON, STEVE; SIMPSON, PETER; WIGHTLIN, MATTHEW D.; PRYOR, JACK; SWANSON, VANCE
To: DEXCOM, INC.
Reel/Frame 052301/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: BRISTER, MARK; PETISCE, JAMES R.; WOO, KUM MING; SAINT, SEAN; NOLTING, JOHN
To: DEXCOM, INC.
Reel/Frame 051848/0435 →
Continuity (6)
Continuation 16674610 · Nov 5, 2019
Continuation 16392521 · Apr 23, 2019
Continuation 14590483 · Jan 6, 2015
Continuation 13909962 · Jun 4, 2013
Continuation 11360262 · Feb 22, 2006
Related Publication 20200178862A1 · Jun 11, 2020
Cited By (13)
US 1,130,752 US 12,187,480 US 12,201,431 US 12,279,865 US 12,318,206 US 12,453,494 US 12,458,257 US 12,458,258 US 12,490,919 US 12,622,622 US 12,642,456 US 12,666,543 US 12,690,787